Chiquita Brooks-LaSure, CMS administrator (Francis Chung/Politico via AP Images)
November 26, 2024 04:09 PM EST
Pharma
FDA+

The Biden ad­min­is­tra­tion wants Medicare and Med­ic­aid to cov­er GLP-1s. Will the Trump White House al­low it?

Nicole DeFeudis

Editor

The Biden ad­min­is­tra­tion pro­posed a new rule Tues­day that would ex­pand Medicare and Med­ic­aid cov­er­age of pop­u­lar obe­si­ty drugs, earn­ing praise from the phar­ma­ceu­ti­cal in­dus­try …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

Will CRISPR mat­ter?

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times